OUObinna Ugwuegbu

Obinna Ugwuegbu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Obinna Ugwuegbu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Traumatic aniridia in a pseudophakic patient 20 years after cataract surgery

    by Matthew N. Henderson, Obinna Ugwuegbu, Pheobe Lin, Michael E. Millstein

    Introduction: Traumatic aniridia in pseudophakic eyes is a rare complication of blunt ocular trauma and has typically been reported months to years after cataract surgery. We report a case of isolated traumatic aniridia occurring 20 years after cataract surgery, the longest reported interval between cataract surgery and traumatic expulsive aniridia. Patient and Clinical Findings: An 88-year-old woman presented with 3 weeks of left eye photophobia and glare after blunt facial trauma. Her ocular history included uneventful phacoemulsification through a 3.0 mm temporal clear corneal incision (CCI) 20 years earlier. Examination demonstrated uncorrected visual acuity of 20/400 improving to 20/30 with pinhole and intraocular pressure of 10 mm Hg. Slitlamp examination revealed complete absence of the iris with direct visualization of an intact intraocular lens–capsular bag complex and zonular fibers. The CCI was Seidel negative but contained pigment and hemorrhage. Diagnosis, Intervention, and Outcomes: The patient had isolated traumatic aniridia presumed secondary to iris extrusion through the prior CCI. Symptoms were managed conservatively with sunglasses. Conclusions: Clear corneal cataract incisions may dehisce during blunt trauma even decades after surgery, acting as a pressure-release pathway that permits iris extrusion while protecting the globe from more severe injury.

  • Open Access

    Longitudinal Ellipsoid Zone Dynamics During Hydroxychloroquine Use

    by Karen Matar, Katherine E. Talcott, Obinna Ugwuegbu, Ming Hu, Sunil K. Srivastava, Jamie L. Reese, Justis P. Ehlers

    Background/Objectives: Hydroxychloroquine (HCQ) retinopathy can be underrecognized early, as structural changes in OCT may precede symptoms and are often subtle. Early detection is crucial to prevent irreversible damage. This study evaluated longitudinal OCT changes preceding overt HCQ toxicity using ellipsoid zone (EZ) mapping. Methods: Patients on long-term HCQ underwent two macular cube scans at least one year apart using Cirrus HD-OCT. Scans were analyzed with an EZ-mapping platform and manually validated. Patients with baseline OCT signs of toxicity or co-existing macular disease were excluded based on masked expert review. Results: Three hundred and seventy-three eyes of 373 patients were included. The mean age was 57.0 ± 12.6 years, the mean HCQ dose was 379.4 ± 59.4 mg, the treatment duration was 5.6 ± 3.7 years, and the OCT interval was 3.1 ± 0.9 years. Outer retinal metrics remained stable across the cohort. The mean en face EZ attenuation increased from 3.3% to 3.9% (p = 0.24). Thirty-four eyes (9.1%) experienced an absolute increase of ≥4% (~1.5 mm2) in EZ attenuation. This increase was significantly associated with age at HCQ initiation (p < 0.001), age at the time of the first and second OCT (p < 0.001), and baseline visual acuity (p = 0.01), and demonstrated changes in other outer retinal metrics (p < 0.01). Only 3/34 eyes (8.9%) were diagnosed by the managing clinician with HCQ toxicity at the time of the second OCT. However, 26 of these eyes (76.5%) had signs of HCQ toxicity by expert review, suggesting the overall greater sensitivity of these quantitative outer retinal metrics for detecting toxicity compared with clinician review. Conclusions: Longitudinal OCT assessment revealed overall stability in outer retinal metrics in eyes on HCQ, but a subset showed increased EZ attenuation, which correlated with age at the time of HCQ initiation, baseline visual acuity, and expert OCT review. These changes may help identify at-risk eyes and eyes with early toxicity and warrant further validation as potential screening biomarkers.